Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
American Journal of Clinical Oncology
|
February 10, 2025
Effect of Rectal Cancer Treatment Timing Standardization on Patient Outcomes
James Sun, Jordan D Fredette, Jill S Hasler, et al.
World Neurosurgery
|
July 4, 2018
Prognostic Factors in Clival Chordomas: An Integrated Analysis of 347 Patients
Yingjie Zou, Natalie Neale, James Sun, et al.
Annals of Surgical Oncology
|
August 7, 2021
Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection
Kristy K Broman, Deepti Bettampadi, Jaileene Pérez-Morales, et al.
Journal of Neuro-Oncology
|
June 21, 2018
Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas
Lei Tang, Lu Deng, Harrison X Bai, et al.
Journal of Surgical Oncology
|
February 9, 2019
Management of intussusception in patients with melanoma
Matthew C Perez, James Sun, Clara Farley, et al.
Oncotarget
|
May 20, 2017
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting
Brian A Dougherty, Zhongwu Lai, Darren R Hodgson, et al.
Melanoma Management
|
August 22, 2020
Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)
James Sun, Brian R Gastman, Lucy McCahon, et al.
Spine
|
November 15, 2017
Prognostic Factors and Treatment of Spinal Astrocytomas: A Multi-institutional Cohort Analysis
Yingjie Zou, James Sun, Yangying Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2013
Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations
Jeffrey S Ross, Kai Wang, Christine E Sheehan, et al.
Cancer
|
January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
American Journal of Clinical Oncology
|
February 10, 2025
Effect of Rectal Cancer Treatment Timing Standardization on Patient Outcomes
James Sun, Jordan D Fredette, Jill S Hasler, et al.
World Neurosurgery
|
July 4, 2018
Prognostic Factors in Clival Chordomas: An Integrated Analysis of 347 Patients
Yingjie Zou, Natalie Neale, James Sun, et al.
Annals of Surgical Oncology
|
August 7, 2021
Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection
Kristy K Broman, Deepti Bettampadi, Jaileene Pérez-Morales, et al.
Journal of Neuro-Oncology
|
June 21, 2018
Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas
Lei Tang, Lu Deng, Harrison X Bai, et al.
Journal of Surgical Oncology
|
February 9, 2019
Management of intussusception in patients with melanoma
Matthew C Perez, James Sun, Clara Farley, et al.
Oncotarget
|
May 20, 2017
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting
Brian A Dougherty, Zhongwu Lai, Darren R Hodgson, et al.
Melanoma Management
|
August 22, 2020
Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)
James Sun, Brian R Gastman, Lucy McCahon, et al.
Spine
|
November 15, 2017
Prognostic Factors and Treatment of Spinal Astrocytomas: A Multi-institutional Cohort Analysis
Yingjie Zou, James Sun, Yangying Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2013
Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations
Jeffrey S Ross, Kai Wang, Christine E Sheehan, et al.
Cancer
|
January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
Page
of 10